


Remains to see if Fed have any tools left in the box to stop this weakening.
Kitron: Q2 2020 – Record performance 10.7.2020 12:46:05 CEST | GlobeNewswire (Excerpt) " (2020-07-10) Kitron today reported strong growth and record profit for the second quarter driven by Defense/Aerospace, Medical devices and Industry sectors. Kitron's revenue for the second quarter was NOK 1 041 million, an increase of 21 per cent compared to last year....
NEL Hydrogen with bank accounts flush after several equity offerings near earlier highs looks set to take part both in the European Hydrogen Economy initiative, as well as an important infrastructure partner of NIKOLA Do you dare to buy at these levels?
ArcticZymes has entered into an agreement with ReiThera to supply its SAN product for ReiThera’s COVID-19 vaccine candidate Tromsø, 02 July, 2020: ArcticZymes AS (OSE:AZT), a subsidiary of ArcticZymes Technologies ASA, announces that it has entered into a supply agreement with vaccine specialist ReiThera Srl (Rome, Italy) for the supply of Salt Active Nuclease...
OMXCOP:GMAB IR: ir.genmab.com Life Science Leader: "The 5-Step Strategy That Saved Genmab From A Dire Outlook" www.lifescienceleader.com
Upon rumours that a law company is researching legal issues for $GRAF connected to the Velodyne merger, the stock is experiencing huge volatility in price, but when looking at volume it is clear that the stock is pulling back on significantly lower volume than was seen during the bullish move. With a keen eye on risk management, the rest of this week could...
$GRAF is on the move this week on speculations that this SPAC will be merging with P&G spinoff PureCycle, which is a Plastics Recycling startup This is a higly interesting very high risk play as the merger may very well not come to fruition. Also look into yesterdays development on the regulatory side: "Plastics recycling bill introduced to Congress" To...
Largest owner in Photocure OSL:PHO apparently being forced to dump the whole position in the stock in the course of a few days, giving the stock extra momentum to the downside. Updated list of shareholders show influx of US actors. twitter.com
Norwegian biotech smoking hot atm
Quote: "Bemcentinib has shown effect against SARS-CoV-2 (coronavirus) in animal models and has been selected as the first of six drugs to be fast-tracked in the new UK initiative (ACCORD) to enter a phase 2 study directly. Although there are many uncertainties around valuing this opportunity, we estimate the new indication adds NOK 21/share, with a new TP of NOK...
www.bergenbio.com
Nordic Mining prepares for lift-off There hasn’t been a greenfield development of a mine in Norway for between 30 and 40 years but Nordic Mining is looking to change that via construction of its flagship Engebo rutile and garnet project. www.mining-journal.com Nordic Minining OSL:NOM just presented their Definitive Feasibility Study for the Nordic Rutile...
Patent covering the use of Blue Light Cystoscopy (BLC®) with Hexvix as neoadjuvant* therapy in the treatment of bladder cancer in patients who are scheduled for a cystectomy. Early stage study results have shown an antitumor effect and induced systemic immune effects of hexaminolevulinate (HAL) and blue light in an orthotopic model of rat bladder cancer....
PCI Biotech: US patent granted for the vaccine technology (fimaVACC) in combination with cytokines Oslo (Norway), 21 January 2020 – PCI Biotech OSL:PCIB , a cancer focused biopharmaceutical company, today announces that the U.S. Patent and Trademark Office (USPTO) has granted the company a US patent covering the use of fimaVacc in combination with...
ABOUT BERGENBIO OSL:BGBIO BerGenBio is a clinical-stage oncology company focused on developing transformative drugs targeting AXL as a potential cornerstone of therapy for aggressive diseases, including immune-evasive, therapy resistant cancers. www.bergenbio.com www.nordnet.no Trinity Delta Analysis: www.trinitydelta.org
PledPharma OMXSTO:PLED with short term positive momentum on top of recent clinical trial updates. Should be kept on watch list as it could break out from a year long consolidation phase. Recent CEO Interview: www.redeye.se PledPharma to initiate one pivotal Phase II/III study with Aladote® for marketing authorisation application in both US and EU ...
Look for sustained rally upwards from 50 day average, powerfull buy signal could be triggered and could move the stock closer to its consensus price target of $13.50 www.smarteranalyst.com NASDAQ:SGMO investor.sangamo.com investor.sangamo.com
www.va.se finansavisen.no PCI Biotech OSL:PCIB is a biopharmaceutical company focusing on development and commercialisation of novel therapeutic solutions for improved treatment of cancer patients through its innovative photochemical internalisation (PCI) technology platform. PCI induces triggered endosomal release that can be used to unlock the...